louisiana glp-1 bowel obstruction lawsuit gastric intestinal legal team gastrointestinal law office in semaglutide gi obstruction louisiana glp-1 gastric intestinal obstruction

It of course totally depends on how accurate or how misleading the LiPo manufacturer is with their claimed C rating

After major weight loss, stretched skin and weakened abdominal tissues often remain, even after reaching a healthy weight

Warning signs requiring prompt medical attention include high fever, severe abdominal pain, bloody stools, or signs of allergic reaction

A study on an older GLP-1 agonist, liraglutide, included data on the weight loss achieved at lower doses, demonstrating effectiveness even during the ramp-up phase

Generic and biosimilar semaglutide: what's actually in the pipeline As of April 2026, the FDA has received zero Abbreviated New Drug Applications (ANDAs) for generic semaglutide